Close Menu

Mass General

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Massachusetts General Hospital is starting a major study aimed at guiding treatment of patients suffering from treatment-resistant major depressive disorder.

Massachusetts General Hospital Cancer Center and Spain's Vall d’Hebrón Institute of Oncology said this week that they will partner to develop personalized cancer treatments.

Massachusetts General Hospital last week published data showing that siRNAs could be used to block inflammation in mice by silencing CCR2 in monocytes.

Pages

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.